Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival

Clinical Cancer Research

Volumn 14, Issue 11, 2008, Pages 3319-3326

  Li, Jun ^a,b   Zhang, Nu ^d   Song, Li Bing ^e   Liao, Wen Ting ^e   Jiang, Li Li ^a,c   Gong, Li Yun ^a,c   Wu, Jueheng ^a,c   Yuan, Jie ^a,b   Zhang, Hui Zhong ^e   Zeng, Mu Sheng ^e   Li, Mengfeng ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Departments of Biochemistry   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^e SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE ELEVATED GENE 1 PROTEIN; GENE PRODUCT; MESSENGER RNA; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; MTDH PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AEG 1 GENE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME; UPREGULATION; BIOSYNTHESIS; BREAST TUMOR; DISEASE COURSE; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL ADHESION MOLECULES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 50349090038     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-4054     Document Type: Article

References (24)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:532-42.
2. Robbins P, Pinder S, de Klerk N, et al. Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 1995;26:873-9.
3. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I.The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology1991;19:403-10.
4. Galea MH, Blarney RW, Elston CE, et al The Nottingham Prognostic Index in primary breast cancer. Breast Cancer ResTreat 1992:22:207-19.
5. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-78
6. Brown DM, Ruoslahti E. Metadherin a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 2004;5:365 - 74.
7. Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RasH. Oncogene 2002; 21:3592-602.
8. Su ZZ, Chen Y Kang DC, et al. Customized rapid subtraction hybridization (RasH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-a treatment Gene 2003:306:67-78
9. Kang DC, Su ZZ, Sarkar D, et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005;353:8-15.
10. kB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 2006;66:1509-16.
11. Lee SG, Su ZZ, Emdad L, et al. Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci U S A 2006:103: 17390-5.
12. Kikuno N, Shiina H, Urakami S, et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOX03a activity. Oncogene 2007;[Epub ahead of print],
13. Emdad L, Sarkar D, Su ZZ, et al. Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 2007; 114: 155-70.
14. Liao WT.Wang HM, Li MZ, et al. Establishment of three-dimensional culture models related to different stages of nasopharyngeal carcinogenesis. Ai Zheng 2005;24:1317-21.
15. Corsaro A.Thellung S, Russo C, et al. Expression in f. coli and purification of recombinant fragments of wild type and mutant human prion protein. Neurochem Int 2002;41:55-63.
16. Hahn WC, Dessain SK, Brooks MW. et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002:22:2111 -23.
17. Greene FL, Page DL, Fleming ID. et al Breast cancer in AJCC cancer staging handbook. TNM classification of malignant tumors. 6th ed. New York Springer Verlag:2002. pp. 255-81.
18. Song LB, Liao WT, Mai HQ. et al. The clinical significance of twist expression in nasopharyngeal carcinoma. Cancer Lett 2006:242:257-64.
19. Geisler SA, Olshan AF. Weissler MC, et al p16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer Clin Cancer Res 2000.8 3445-53.
20. Fukuoka J, Fuji T, Shih JH, et al. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer Clin Cancer Res 2004:10:4314-24.
21. Schubbert S. Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007:7:295-308.
22. Graham K, Olson MF The ras signalling pathway as a target in cancer therapy. Recent Results Cancer Res 2007;172:125-53.
23. Rodriguez-Viciana P, Tetsu O. Oda K. et al. Cancer targets in the Ras pathway Cold Spring Harb Symp Quant Biol 2005:70:461 - 7
24. Schubbert S, Bollag G, Shannon K. Deregulated Ras signaling in developmental disorders: new tricks for an old dog. Curr Opin Genet Dev 2007 17:15-22.